Gheuens Sarah sold AGIO
October 22, 2026 · Form 4 insider transaction
Gheuens Sarah sold 500 shares of Agios Pharmaceuticals, Inc. at $37.52 per share, a transaction worth $18.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
500
Price
$37.52
Total value
$18.8K
InsiderGheuens Sarah
Role—
SecurityCommon stock
Transaction codeS: Open-market sale
Transaction dateOctober 22, 2026
Filing dateOctober 23, 2026
Shares owned after54,645
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.